Yetukuri L, Ekroos K, Vidal-Puig A, Oresic M. The global problem of antifungal resistance: prevalence, mechanisms, and management. Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. Te Welscher YM, ten Napel HH, Balagué MM, Souza CM, Riezman H, de Kruijff B, et al. Amphotericin B: time for a new “gold standard”. Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH. An insight into the antifungal pipeline: selected new molecules and beyond. Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. Heidary M, Khosravi AD, Khoshnood S, Nasiri MJ, Soleimani S, Goudarzi M. Molecular mechanisms of membrane targeting antibiotics. Application of marine natural products in drug research. Marine Pharmacology in 2016-2017: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral activities affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mayer AMS, Guerrero AJ, Rodríguez AD, Taglialatela-Scafati O, Nakamura F, Fusetani N.
Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates. McCauley EP, Piña IC, Thompson AD, Bashir K, Weinberg M, Kurz SL, et al. Retrospective analysis of natural products provides insights for future discovery trends. Pye CR, Bertin MJ, Lokey RS, Gerwick WH, Linington RG. Carroll AR, Copp BR, Davis RA, Keyzers RA, Prinsep MR.
0 kommentar(er)
